Find Beta-Glucono-1,5-Lactone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

0

USDMF

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

NDC API

0

VMF

0

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FINISHED DOSAGE FORMULATIONS

0

Europe

0

Canada

0

Australia

0

South Africa

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Delta-gluconolactone, 90-80-2, D-glucono-1,5-lactone, Gluconic acid lactone, D-gluconolactone, 1,5-gluconolactone
Molecular Formula
C6H10O6
Molecular Weight
178.14  g/mol
InChI Key
PHOQVHQSTUBQQK-SQOUGZDYSA-N
FDA UNII
WQ29KQ9POT

Beta-Glucono-1,5-Lactone
Gluconolactone is a naturally occurring polyhydroxy acid (PHA) with metal chelating, moisturizing and antioxidant activity. Gluconolactone can be produced by enzymatic oxidation of D-glucose oxidation. Its ability in free radicals scavenging accounts for its antioxidant property. It is used in cosmetic product and as a coagulant in tofu processing. (NCI05)
Gluconolactone is a Calculi Dissolution Agent. The mechanism of action of gluconolactone is as an Irrigation.
1 2D Structure

Beta-Glucono-1,5-Lactone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-one
2.1.2 InChI
InChI=1S/C6H10O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-5,7-10H,1H2/t2-,3-,4+,5-/m1/s1
2.1.3 InChI Key
PHOQVHQSTUBQQK-SQOUGZDYSA-N
2.1.4 Canonical SMILES
C(C1C(C(C(C(=O)O1)O)O)O)O
2.1.5 Isomeric SMILES
C([C@@H]1[C@H]([C@@H]([C@H](C(=O)O1)O)O)O)O
2.2 Other Identifiers
2.2.1 UNII
WQ29KQ9POT
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Beta-glucono-1,5-lactone

2. Delta-gluconolactone

3. Gdl (gluconate)

4. Gluconic Lactone

5. Glucono-delta-lactone

6. Gulonic Acid Gamma-lactone

2.3.2 Depositor-Supplied Synonyms

1. Delta-gluconolactone

2. 90-80-2

3. D-glucono-1,5-lactone

4. Gluconic Acid Lactone

5. D-gluconolactone

6. 1,5-gluconolactone

7. Glucono Delta-lactone

8. D-(+)-glucono-1,5-lactone

9. D-gluconic Acid Lactone

10. D-gluconic Acid Delta-lactone

11. 1,5-d-gluconolactone

12. (3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-one

13. Gluconic Lactone

14. Glucono Delta Lactone

15. Gluconic Delta-lactone

16. Fujiglucon

17. D-delta-gluconolactone

18. Delta-d-gluconolactone

19. Deltagluconolactone

20. (3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-one

21. D-gluconic Delta-lactone

22. D-(+)-gluconic Acid Delta-lactone

23. Glucarolactone

24. Glucono-delta-lactone

25. D-aldonolactone

26. Beta-glucono-1,5-lactone

27. D-gluconic Acid-delta-lactone

28. Gluconolactone [usp]

29. Lysactone

30. Riken Lactone

31. D-threo-aldono-1,5-lactone

32. 1335-57-5

33. Ai3-19578

34. Gluconic Acid Anhydride

35. Gluconic Acid, Delta-lactone, D-

36. Glucono .delta. Lactone

37. Glucono .delta.-lactone

38. .delta.-d-gluconolactone

39. Wq29kq9pot

40. 4253-68-3

41. Gluconic Acid Delta-lactone

42. Ins No.575

43. Chebi:16217

44. D-gluconic Acid .delta.-lactone

45. Ins-575

46. Nsc-34393

47. Nsc-758238

48. Gluconolactone (usp)

49. E-575

50. Nsc 34393

51. Dsstox_cid_6549

52. (3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-one

53. Dsstox_rid_78147

54. Dsstox_gsid_26549

55. 135820-79-0

56. D-gluconic Acid, .delta.-lactone

57. Glucolactone

58. D-gluconic Acid D-lactone

59. (3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2h-pyran-2-one

60. Cas-90-80-2

61. .delta.-gluconolactone

62. D-glucono-delta-lactone

63. Lgc

64. Hsdb 488

65. D-gluconic Acid-1,5-lactone

66. Einecs 202-016-5

67. Unii-wq29kq9pot

68. Gluconic Acid Lactone (6ci)

69. Nsc34393

70. Delta-gluconic Acid Delta-lactone

71. Glucono--lactone

72. Gluconodeltalactone

73. Delta-aldonolactone

74. Gluconate, Lactone

75. Ncgc00095002-01

76. Delta Gluconolactone

77. Gamma-gluconolactone

78. Gdl

79. D-glucono-d-lactone

80. Mfcd00006647

81. Glucono Gamma-lactone

82. Glucono-1,5-lactone

83. Glucono 1,5-lactone

84. D-glucono1,5-lactone

85. Gluconic Acid D-lactone

86. Delta-delta-gluconolactone

87. 1,5-delta-gluconolactone

88. Bmse000230

89. Delta-gluconic Acid Lactone

90. Delta-glucono-delta-lactone

91. Ec 202-016-5

92. Gluconolactone [ii]

93. Gluconolactone [mi]

94. Delta-glucono-1,5-lactone

95. Delta-gluconic Delta-lactone

96. Glucono-delta-lactone(gdl)

97. Schembl15320

98. Gluconolactone [hsdb]

99. Gluconolactone [inci]

100. Delta-gluconic Acid D-lactone

101. Mls002207105

102. D-gluconic Acid 1,5-lactone

103. Gluconolactone [mart.]

104. Gluconolactone [usp-rs]

105. Gluconolactone [who-dd]

106. Chembl1200829

107. D-(+)-gluconic Acid D-lactone

108. Dtxsid0026549

109. Delta-gluconic Acid 1,5-lactone

110. Delta-gluconic Acid-1,5-lactone

111. Delta-gluconic Acid-delta-lactone

112. D(+)-gluconic Acid Gamma-lactone

113. Glucono-

114. A-lactone Usp26 Fcciv

115. Cs-m3768

116. D-(+)-gluconic Acid-delta Lactone

117. Delta-(+)-gluconic Acid D-lactone

118. Glucono Delta-lactone [fcc]

119. Hy-i0301

120. Zinc2539702

121. Gluconolactone [orange Book]

122. Tox21_111383

123. Tox21_200429

124. Bdbm50366565

125. Glucono-delta-lactone [vandf]

126. Gluconolactone [usp Monograph]

127. Akos016843888

128. Tox21_111383_1

129. Db04564

130. Delta-(+)-gluconic Acid-delta Lactone

131. Ds-4779

132. Ncgc00257983-01

133. Ncgc00344522-01

134. Renacidin Component Gluconolactone

135. Ac-13150

136. E575

137. Smr001306715

138. Gluconolactone Component Of Renacidin

139. G0039

140. C00198

141. D04332

142. P19765

143. D-(+)-gluconic Acid Delta-lactone, >=99.0%

144. Gluconolactone, Meets Usp Testing Specifications

145. Q114174

146. W-100325

147. 3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-one

148. 3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-one

149. D-(+)-gluconic Acid Delta-lactone, Analytical Standard

150. Wurcs=2.0/1,1,0/[a2122h_1-5]/1/

151. A88519cb-a562-4c9c-b925-0a6b1701f841

152. Gluconolactone, United States Pharmacopeia (usp) Reference Standard

153. (3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydropyran-2-one

154. (3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-one (non-preferred Name)

155. (3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-one; Gluconolactone

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 178.14 g/mol
Molecular Formula C6H10O6
XLogP3-2
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count6
Rotatable Bond Count1
Exact Mass178.04773803 g/mol
Monoisotopic Mass178.04773803 g/mol
Topological Polar Surface Area107 Ų
Heavy Atom Count12
Formal Charge0
Complexity181
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Therapeutic Uses

MEDICATION (VET): ...Mixture in urine helps dissolve urinary tract stones containing calcium carbonate, tricalcium phosphate, calcium oxalates, & magnesium ammonium phosphates but usually none containing uric acid, urates, cystineine, or some oxalates.

Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 240


MEDICATION (VET): 0.5% Solution can be used for irrigating the urethra & bladder when indicated. Similar strength as a rinse can help maintain in dwelling urethral catheters free of calcification.

Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 240


5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Active Moiety
GLUCONOLACTONE
5.1.2 FDA UNII
WQ29KQ9POT
5.1.3 Pharmacological Classes
Mechanisms of Action [MoA] - Irrigation

FDF Dossiers

read-more
read-more

01

Estilad

Canada
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

Estilad

Canada
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Sodium DNA; Sodium Hyaluronate; Sodium Chloride; GLYCERIN; GLUCONOLACTONE; Sodium Benzoate; Calcium Gluconate

Brand Name :

Dosage Form : Solution

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Canada

blank

02

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE

Brand Name : RENACIDIN

Dosage Form : SOLUTION;IRRIGATION

Dosage Strength : 6.602GM/100ML;198MG/100ML;3.177GM/100ML

Packaging :

Approval Date : 1990-10-02

Application Number : 19481

Regulatory Info : RX

Registration Country : USA

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

read-more
read-more

01

Estilad

Canada
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

Estilad

Canada
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Sodium DNA; Sodium Hyaluronate; Sodium Chloride; GLYCERIN; GLUCONOLACTONE; Sodium Benzoate; Calcium Gluconate

Brand Name :

Dosage Form : Solution

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Canada

blank

01

Estilad

Canada
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

Estilad

Canada
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Sodium DNA; Sodium Hyaluronate; Sodium Chloride; GLYCERIN; GLUCONOLACTONE; Sodium Benzoate; Calcium Gluconate

Dosage : Solution

Dosage Strength :

Brand Name :

Approval Date :

Application Number :

Registration Country : Canada

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more
FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs
This week, PharmaCompass brings you key highlights of the US Food and Drug Administration’s December 2025 list of Off-Patent, Off-Exclusivity Drugs (OPOE) without an approved generic. The OPOE list gets updated every six months.This list highlights drug products that have lost patent protection and regulatory exclusivity, but remain without approved generic competition in the US market. With this list, the FDA hopes to bolster competitiveness in the generics market, improve transparency and encourage the development and submission of abbreviated new drug applications (ANDAs) in markets with little competition.Since December 2021, FDA has been publishing two versions of the OPOE list — one for prescription (Rx) drug products and the other for over-the-counter (OTC) drug products that are approved and marketed under a new drug approval (NDA).  Access the Interactive Dashboard on FDA's December 2025 List of OPOE Drugs (Free Excel)Injectables continue to dominate FDA’s OPOE Rx list; 73 OTC drugs figure in Dec listFDA’s December 2025 OPOE Rx list includes 784 drug products that currently have no approved generics. Out of these, 296 are injectables and 126 are oral solid dosage forms (such as tablets, capsules and modified release forms). In June 2025, the OPOE Rx list had 765 drug products without an approved generic, out of which 304 were injectables, while 109 were oral solid drug forms. The increase in drug products from 765 to 784 from June 2025 to December 2025 was due to the inclusion of additional dosage strengths in the OPOE Rx list. Otherwise, no new drugs were added to the December 2025 OPOE Rx list.The December 2025 OPOE list has 73 OTC drugs, slightly higher than the 69 drugs in the June 2025 list. Among the 73, 21 are oral solid dosage forms.Among the OTC drugs on the December 2025 OPOE list are ibuprofen and ibuprofen sodium (for pain and inflammation), pseudoephedrine hydrochloride and phenylephrine hydrochloride (nasal decongestants), nizatidine and famotidine (for gastroesophageal reflux disease), loratadine, cetirizine hydrochloride and chlorpheniramine maleate (for allergy relief), loperamide hydrochloride (anti-diarrheal), and orlistat (for weight management). Access the Interactive Dashboard on FDA's December 2025 List of OPOE Drugs (Free Excel)FDA fast-tracks initiatives to accelerate market entry of generics, biosimilarsFDA has launched several regulatory initiatives designed to accelerate the market entry of generics and biosimilars. In October 2025, the agency announced a new pilot prioritization program for the review of ANDAs that aims to encourage and reward investment in drug manufacturing, research and development and strengthen the pharmaceutical supply chain in the United States.Separately, FDA has also come out with a new draft guidance that seeks to simplify biosimilarity studies and reduce unnecessary clinical testing. Through a separate initiative, the agency also plans to make it easier for biosimilars to be developed as interchangeable with brand-name biologics, thereby helping patients and pharmacists choose lower-cost options. Access the Interactive Dashboard on FDA's December 2025 List of OPOE Drugs (Free Excel) Our viewThe global generic drugs market was valued at US$ 445.62 billion in 2024 and is projected to reach US$ 728.64 billion by 2034, growing at a compound annual growth rate of 5.04 percent from 2025 to 2034. With several diabetes, immunology, oncology and cardiology drugs slated to face patent expirations this year, and continued pressure on drugmakers to improve affordability, we believe the generic market could grow at an even faster rate in the near term.

Impressions: 3090

https://www.pharmacompass.com/radio-compass-blog/fda-s-december-2025-opoe-list-features-784-prescription-drugs-73-otc-drugs

#PharmaFlow by PHARMACOMPASS
22 Jan 2026

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 90-80-2 / Beta-Glucono-1,5-Lactone API manufacturers, exporters & distributors?

Beta-Glucono-1,5-Lactone manufacturers, exporters & distributors 1

88

PharmaCompass offers a list of Beta-Glucono-1,5-Lactone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Beta-Glucono-1,5-Lactone manufacturer or Beta-Glucono-1,5-Lactone supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Beta-Glucono-1,5-Lactone manufacturer or Beta-Glucono-1,5-Lactone supplier.

API | Excipient name

Beta-Glucono-1,5-Lactone

Synonyms

Delta-gluconolactone, 90-80-2, D-glucono-1,5-lactone, Gluconic acid lactone, D-gluconolactone, 1,5-gluconolactone

Cas Number

90-80-2

Unique Ingredient Identifier (UNII)

WQ29KQ9POT

About Beta-Glucono-1,5-Lactone

Gluconolactone is a naturally occurring polyhydroxy acid (PHA) with metal chelating, moisturizing and antioxidant activity. Gluconolactone can be produced by enzymatic oxidation of D-glucose oxidation. Its ability in free radicals scavenging accounts for its antioxidant property. It is used in cosmetic product and as a coagulant in tofu processing. (NCI05)

Beta-Glucono-1,5-Lactone Manufacturers

A Beta-Glucono-1,5-Lactone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Beta-Glucono-1,5-Lactone, including repackagers and relabelers. The FDA regulates Beta-Glucono-1,5-Lactone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Beta-Glucono-1,5-Lactone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Beta-Glucono-1,5-Lactone Suppliers

A Beta-Glucono-1,5-Lactone supplier is an individual or a company that provides Beta-Glucono-1,5-Lactone active pharmaceutical ingredient (API) or Beta-Glucono-1,5-Lactone finished formulations upon request. The Beta-Glucono-1,5-Lactone suppliers may include Beta-Glucono-1,5-Lactone API manufacturers, exporters, distributors and traders.

Beta-Glucono-1,5-Lactone GMP

Beta-Glucono-1,5-Lactone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Beta-Glucono-1,5-Lactone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Beta-Glucono-1,5-Lactone GMP manufacturer or Beta-Glucono-1,5-Lactone GMP API supplier for your needs.

Beta-Glucono-1,5-Lactone CoA

A Beta-Glucono-1,5-Lactone CoA (Certificate of Analysis) is a formal document that attests to Beta-Glucono-1,5-Lactone's compliance with Beta-Glucono-1,5-Lactone specifications and serves as a tool for batch-level quality control.

Beta-Glucono-1,5-Lactone CoA mostly includes findings from lab analyses of a specific batch. For each Beta-Glucono-1,5-Lactone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Beta-Glucono-1,5-Lactone may be tested according to a variety of international standards, such as European Pharmacopoeia (Beta-Glucono-1,5-Lactone EP), Beta-Glucono-1,5-Lactone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Beta-Glucono-1,5-Lactone USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty